Epstein–Barr Virus and Human Endogenous Retrovirus in Japanese Patients with Autoimmune Demyelinating Disorders
International Journal of Molecular Sciences · 2023
DOI: 10.3390/ijms242417151 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Davide Cossu und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Juntendo University, Tokyo 1138431, Japan. Hauptthemen laut MEDLINE: Endogenous Retroviruses, Epstein-Barr Virus Infections, Multiple Sclerosis, Neuromyelitis Optica. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Society for the Promotion of Science, PRIN 2022, JSPS KAKENHI.
Abstract (Originalsprache)
Multiple sclerosis (MS), neuromyelitis optica spectrum disorder (NMOSD), and myelin oligodendrocytes glycoprotein-antibody disease (MOGAD) are distinct autoimmune demyelinating disorders characterized by varying clinical and pathological characteristics. While the precise origins of these diseases remain elusive, a combination of genetic and environmental factors, including viral elements, have been suggested as potential contributors to their development. Our goal was to assess the occurrence of antibodies against pathogenic peptides associated with Epstein–Barr virus (EBV) and the human endogenous retrovirus-W (HERV-W) in serum samples obtained from Japanese individuals diagnosed with MS, NMOSD, and MOGAD and to make comparisons with a group of healthy controls (HCs). We conducted a retrospective analysis involving 114 Japanese participants, comprising individuals with MS (34), NMOSD (20), MOGAD (20), and HCs (40). These individuals were tested using a peptide-based enzyme-linked immunosorbent assay. A marked increase in antibody response against EBV nuclear antigen 1 (EBNA1)386–405 was observed in the serum of MS and MOGAD patients, as compared to HCs. Notably, we observed a correlation between antibodies against EBNA1386–405 and HERV-W486–504 peptides in a subset of the antibody-positive MS patients. These findings emphasize the involvement of EBV in the pathogenesis of MS and potentially MOGAD, suggesting its role in the reactivation of HERV-W.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology, Juntendo University, Tokyo 1138431, Japan.
- Biomedical Research Core Facilities, Juntendo University, Tokyo 1138431, Japan.
- Department of Biomedical Sciences, Sassari University, 07100 Sassari, Italy.
- Struttura Complessa di Microbiologia e Virologia, Azienda Ospedaliera Universitaria, 07100 Sassari, Italy.
- Neurodegenerative Disorders Collaborative Laboratory, RIKEN Center for Brain Science, Saitama 3510918, Japan.
ORCID-Profile: Yuji Tomizawa, Leonardo Antonio Sechi, Nobutaka Hattori
Förderung
- Japan Society for the Promotion of Science
- PRIN 2022
- JSPS KAKENHI
Zitieren
APA
Cossu, D., Tomizawa, Y., Sechi, L. A., & Hattori, N. (2023). Epstein–Barr Virus and Human Endogenous Retrovirus in Japanese Patients with Autoimmune Demyelinating Disorders. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms242417151
Vancouver
Cossu D, Tomizawa Y, Sechi LA, Hattori N. Epstein–Barr Virus and Human Endogenous Retrovirus in Japanese Patients with Autoimmune Demyelinating Disorders. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms242417151
BibTeX
@article{Cossu2023,
author = {Cossu, Davide and Tomizawa, Yuji and Sechi, Leonardo Antonio and Hattori, Nobutaka},
title = {Epstein–Barr Virus and Human Endogenous Retrovirus in Japanese Patients with Autoimmune Demyelinating Disorders},
journal = {International Journal of Molecular Sciences},
year = {2023},
doi = {10.3390/ijms242417151}
}
EUVIMED